Focal Segmental Glomerulosclerosis (FSGS) Treatment Top Companies

  1. Roche

  2. Genentech

  3. Novartis

  4. Merck

  5. Travere Therapeutics Inc.

*Disclaimer: Top companies sorted in no particular order

Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Major Players

Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Concentration

Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Concentration

Focal Segmental Glomerulosclerosis (FSGS) Treatment Company List

  • Roche

  • Genentech

  • Novartis

  • Merck

  • Teva Pharmaceutical Industries

  • Travere Therapeutics Inc.

  • Vertex Pharmaceuticals

  • AstraZeneca

  • Pfizer

  • Bristol-Myers Squibb

  • Otsuka Pharmaceutical Co. Ltd.

  • Equillium Inc.

  • Goldfinch Bio

  • Reata Pharmaceuticals Inc.

  • Ionis Pharmaceuticals

  • Chinook Therapeutics Inc.

  • Omeros Corporation

  • LabCorp

  • Arkana Laboratories

  • Allina Health Laboratory

Need More Details on Market Players and Competitors?
Download PDF

Focal Segmental Glomerulosclerosis (FSGS) Treatment Report Snapshots